Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
Irbesartan
ODYSSEY Outcomes
Odyssey Outcomes - Mortality
The EXPLORER Study
The ACTE Study
NEJM Odyssey Outcomes
The ROSETTE Study
Odyssey Outcomes - PVD Results
Changing trends in VTE: Pulmonary Embolism Cases on Rise within the Last Decade
VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients
Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism
PCSK9 inhibitors and ACS
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients
Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism
PCSK9 inhibitors and ACS
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress
Atherosclerotic Cardiovascular Disease Risk Assessment
PCSK9i and Prevention of CVD
APSC Consensus Recommendations on Dyslipidemia
Single-Pill Combinations in Dyslipidemia
%20from%20the%20SAFEHEART%20registry.jpeg 767w, /.imaging/webp/sanofi-platform/img400x300/dam/hcp-portal-gulf/images/science/cardiovascular/dyslipidemia/Clinical-practice-experience-in-patients-with-familial-hypercholesterolemia--FH--from-the-SAFEHEART-registry.jpeg/jcr:content/Clinical%20practice%20experience%20in%20patients%20with%20familial%20hypercholesterolemia%20(FH)%20from%20the%20SAFEHEART%20registry.jpeg 1200w)
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry
PCSK9 Inhibitors in Cardiovascular Disease
VTE Risk Assessment in Surgical Patients
Evaluation of lipid management following ACS
Events
Stay up to date and register for the latest events and view webinar recordings.
CardioRisk WebApp
Venous Thromboembolism Burden
Sanofi Thrombosis Summit
Hypertension and CVD
World Hypertension Day Ep. 1
World Hypertension Day Ep. 2
Dyslipidemia Webinars: Optimizing Dyslipidemia management
06:58
VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery
Challenges of VTE Prophylaxis in Surgery
Hypertension - The Most Important Disease in Medicine
Dyslipidemia Webisodes: Mortality data with Prof. Tunon
